2024 Health Meeting - Session 6D: Measuring Effectiveness of Diabetes Interventions 6.25.24 Recording

Patients with diabetes make up 25% of health care spending in the US, and a variety of solutions to address the high cost of diabetes exist today, including disease management programs, clinical interventions including bariatric surgery and GLP-1 drugs, and food as medicine programs. Actuaries are routinely tasked with evaluating the effectiveness of such programs and this session will review the cost effectiveness of each type of program. Attendees will learn which population each intervention may be most effective for, how each intervention may or may not address social determinants of health that lead to the development of diabetes, and examples of short and long term results for each intervention type. Attendees will be better positioned to evaluate each type of diabetes intervention, as well as learn about considerations that come with the implementation and evaluation of these type of interventions that could help inform strategy for their clients or organization.